The survival of children with cancer has substantially increased over the last decades. However, despite continuous progress in the field, the disease itself and associated therapies carry the burden of an array of adverse late effects. The literature suggests that up to 46% of children and young adults with cancer experience malnutrition due to numerous tumor- and treatment-related factors. It is recognized that a diminished nutritional status may be a contributing factor for decreased immune function, delayed wound healing, and disturbed drug metabolism influencing prognosis. Children with cancer are particularly vulnerable to malnutrition, because they exhibit elevated nutrient needs due to the disease and its treatment. At the same time, children have increased requirements of nutrients to attain appropriate growth and neurodevelopment. It has been demonstrated that adequate nutrition plays a decisive role on several clinical outcome measures such as treatment response, quality of life, and cost of care.
Malnutrition
While it is proposed that a loss in body weight of more than 5% constitutes acute malnutrition and a height-for-age value below the 5th percentile may reflect chronic undernourishment in children, many children suffering from cancer do not meet these criteria. Nutritional depletion may furthermore be masked in children by edema due to corticosteroid treatment. A number of pathophysiological mechanisms contribute to the development of malnutrition and growth failure in childhood cancer.
- Simple starvation
- Cancer cachexia
- Excessive Cytokines (proinflammatory cytokines IL1α, IL-1β, and IL-6 released by tumor tissue, immune and stroma cells, TNFα, and INFγ in combination with other mediators affect food intake and energy expenditure,
- Imbalanced Leptin levels (reduceding appetite)
- Energy deficits and metabolic abnormalities
- Metabolic effects of cancer and chemotherapeutic agents create endocrine disturbances such as impaired production of thyroid hormones, intense diarrhea, vomiting, mucositis, and systemic effects of therapy, contributing to fluid loss, electrolyte and trace elements imbalance, and alterations of their carrier proteins, as well as iron and vitamin deficiency that may result in acute and chronic malabsorption of micro- and macronutrients.
Individuals with cancer exhibiting pronounced weight loss demonstrate decreased survival rates, diminished response to cytostatics, prolonged hospital stays, higher rates of readmissions, and a reduced quality of life.
The growing child is more susceptible to long-term diseases that have implications for later life. Comparing the BMI of pediatric cancer survivors to the general population of similar age, it has been demonstrated that survivors of specific cancer types are more likely to be underweight. At the same time, it has been realized that survivors of common pediatric malignancies are at risk for adult-onset diseases such as obesity, which is associated with a high risk for cardiovascular and endocrine diseases.
Methods to Detect and Analyze Poor Nutritional Status
Common anthropometric tests involve measurements of stature, body weight, and BMI that should be measured on admission and at follow-up points in all affected children so that trends can be identified. To ascertain the head circumference is an important aspect of nutritional evaluation, especially in the young ill child, to avoid disturbances in neurodevelopmental outcome throughout critical periods of brain growth. Selected complementary biochemical markers such as plasma protein, pre-albumin, retinol-binding protein, transthyretin, and transferrin have restricted usefulness in the recognition of malnutrition in children with cancer and in critically ill children due to the fact that these variables are influenced by fewer inflammations and infections.
Chemotherapy and recurrent episodes of sepsis may deplete the body of the essential macro- and micronutrients needed for appropriate growth and metabolism, especially zinc. Recently developed nutritional risk scores for adults and children should be a part of the evaluation of malnutrition in patients with cancer. Enteral analyses of substrate losses through stools for the calculation of energy needs adapting nutritional support to individual intestinal permeability are useful in children with marked intestinal complications.
Nutritional Support
At the present time, no universally agreed specific substrate requirements, criteria for, timing of, and duration of nutritional interventions exist in pediatric oncology. This is a huge problem. The primary objectives of nutritional interventions in pediatric oncology should be: the maintenance of body stores as close to the ideal as possible, minimization of wasting, promotion of appropriate growth development, and providing a good quality of life. Nutrition strategies are indicated in all affected children, beginning with the diagnosis of cancer to prevent and/or restore abnormalities in growth development before nutritional and general status are severely compromised. These should be integrated into cancer treatment protocols starting directly after admission independent of the initial body weight to establish the essential role of adequate nutrition in the mind of the child and parents. The assessment of the nutritional status is indispensable to stratify the child into nutritional risk groups in view of actual nutritional condition and the extent of the disease, considering psychological and socioeconomic aspects as well as the prescribed multimodal procedures for each tumor type.
Nutritional Strategies
It is without doubt that the enteral route is the preferred and safest way for the provision of nutrition in any child with an undamaged and functional gastrointestinal tract, preventing intestinal atrophy, toxicity, and complications of i.v. infusion. Depending on gastric tolerance and pretenses of the child depending on family participation, an individualized nutritional schedule should be prepared. The selection of further means of support depends on the capability of oral intake, gut stability, absorption rate, and the possibility of expected adverse effects.
- Exogenous glutamine application appears to play a role in diminishing the detrimental effects of anticancer drugs on the gastrointestinal mucosa.
- Carnitine supplementation has been suggested to improve the cancer fatigue syndrome by influencing nutritional and immunological parameters.
- Currently available therapeutic approaches for the management of cancer cachexia are megestrol acetate, a synthetic derivate of progesterone; anabolic steroids, such as testosterone derivatives; and the peptide hormones ghrelin and ghrelin agonists. The use of these agents is critical in children concerning the associated side effects on a growing and immature organism.
- High-energy protein formulas and liquid supplements are offered to increase energy density.
- A balanced diet with sufficient proteins and high energy levels is required to prevent an extreme overload of carbohydrate and fat consumption, as seen in many children with cancer.
- Working with an dietetic and nutritional expert is paramount. Unfortunately there are very few of them out there.
The importance of nutrition in children and young adults with cancer is an underestimated topic within pediatric oncology. There are new, inexpensive, and noninvasive techniques for the evaluation of the nutritional status providing evidence for the quality of nutritional interventions for children with a high risk of undernutrition and a tendency for body fat accumulation. Malnutrition in children with cancer should not be accepted at any stage of the disease or tolerated as an inevitable process. Nutritional strategies should be considered and integrated as a fundamental feature of pediatric oncology with the same diligence as one does for other supportive care measures to prevent chronic illness and adverse late effects caused by malnutrition in this population.